Biogen(BIIB)
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Aduhelm | Aducanumab | 2021-06-07 | ||
| Avonex | Interferon beta-1a | 1996-05-17 | ||
| Fampyra | Dalfampridine | 2011-07-20 | ||
| Plegridy | Peginterferon beta-1a | 2014-08-15 | ||
| Rituxan | Rituximab | 2002-02-19 | ||
| Spinraza | Nusinersen | 2016-12-23 | 2023-2035 | |
| Tecfidera | Dimethyl fumarate | 2013-03-27 | 2028-2035 | |
| Tysabri | Natalizumab | 2004-11-23 | ||
| Vumerity | Diroximel fumarate | 2019-10-29 | 2033 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use